MRV Engenharia e Participações (MRVE3) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
1 Jun, 2026Strategic evolution and business cycle
Expanded from engineering to a diversified housing platform, including international operations and spin-offs.
Business cycle phases: growth, stabilization, diversification, turnaround, and pursuit of operational excellence.
Gross margin and cash generation fluctuated with market cycles, peaking during expansion and stabilizing during efficiency drives.
Recent focus on turnaround and margin improvement through cost control and operational optimization.
No new U.S. projects planned; focus on portfolio review and efficiency.
Financial and operational performance
Net pre-sales projected to reach R$10 billion in 2025, with gross margin targets of 35% for new sales.
Launches and built units expected to remain above 30,000 annually through 2026.
Gross margin improved from 19.3% in 2022 to a projected 31% in 1Q26.
EBITDA and net revenue are forecasted to grow steadily, supporting cash generation and profitability.
Margin expansion and cost optimization
Margin equation driven by lower land costs, optimized product design, efficient execution, and price increases above inflation.
Land costs as a percentage of net revenue are declining, aided by capital city acquisitions and land swaps.
Product simplification and redesign reduced unit costs by up to R$5,000.
Sequenced production and industrialization increased productivity and reduced capex.
Price increases consistently outpaced inflation, with technology supporting dynamic pricing and sales conversion.
Latest events from MRV Engenharia e Participações
- Record pre-sales and margin recovery drive strong outlook, but US losses persist.MRVE3
Q2 202419 May 2026 - Record margins, strong sales, and US asset divestment drive outlook for further growth in 2026.MRVE3
Q4 202519 May 2026 - Revenue and launches surged, but cash flow was hit by transfer delays and US impairments.MRVE3
Q1 202519 May 2026 - Strong revenue growth, margin expansion, and deleveraging amid regulatory and operational tailwinds.MRVE3
Q3 202519 May 2026 - Margin expansion, operational excellence, and asset-light strategy drive future growth.MRVE3
Investor Day 202618 May 2026 - Net revenue rose 18% and adjusted net profit reached R$133 million, with robust cash generation.MRVE3
Q1 202614 May 2026 - Margin recovery, cost control, and capital optimization drive sustainable growth.MRVE3
Corporate presentation13 Apr 2026 - Record pre-sales and cash generation drive robust Q3 2024 performance and outlook.MRVE3
Q3 202414 Jan 2026 - Record sales, margin gains, and cash generation in 2024 set up strong 2025 growth and deleveraging.MRVE3
Q4 202417 Dec 2025